Cytarabine 1000 mg for intravenous and s / c injections Kocak, Turkey
Interchangeable drugs with the same active substance:
Alexan
Viztar
Laracite
Cytarabine
Cytarabine-Health
Cytosar
Citazar
Indications:
Achieving and maintaining remission in acute non-lymphoblastic leukemia in adults and children.
Treatment of other types of leukemia, such as acute lymphocytic leukemia, chronic myeloid leukemia (blast crisis).
Prevention or treatment of leukemic meningitis intrathecally as monotherapy or in combination with other drugs (methotrexate, hydrocortisone).
Cytarin ® can be used as monotherapy or in combination with other antineoplastic agents; the best results are usually achieved with complex treatment. Remissions induced by cytarine ® are short-lived without further maintenance therapy.
Therapy of leukemia with a high risk of complications, refractory leukemia and relapse of acute leukemia, regardless of the concomitant use of high doses of antitumor chemotherapeutic agents.
As part of combination therapy (LSA2L2) for the treatment of non-Hodgkin's lymphomas in children.
Cytarin ® has been experimentally used to treat various types of neoplasms. The study resulted in the following observation: a small number of patients with solid tumors had a positive response to treatment.
-
Commercial name:Cytarabine
-
Dosage:1000 mg
-
Release form:Bottle
-
Виробник:Kocak, турция